Abstract:Chronic exposure to opiates impairs hippocampal long-term potentiation (LTP) and spatial memory, but the underlying mechanisms remain to be elucidated. Given the well known effects of adenosine, an important neuromodulator, on hippocampal neuronal excitability and synaptic plasticity, we investigated the potential effect of changes in adenosine concentrations on chronic morphine treatment-induced impairment of hippocampal CA1 LTP and spatial memory. We found that chronic treatment in mice with either increasing doses (20-100 mg/kg) of morphine for 7 d or equal daily dose (20 mg/kg) of morphine for 12 d led to a significant increase of hippocampal extracellular adenosine concentrations. Importantly, we found that accumulated adenosine contributed to the inhibition of the hippocampal CA1 LTP and impairment of spatial memory retrieval measured in the Morris water maze. Adenosine A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine significantly reversed chronic morphine-induced impairment of hippocampal CA1 LTP and spatial memory. Likewise, adenosine deaminase, which converts adenosine into the inactive metabolite inosine, restored impaired hippocampal CA1 LTP. We further found that adenosine accumulation was attributable to the alteration of adenosine uptake but not adenosine metabolisms. Bidirectional nucleoside transporters (ENT2) appeared to play a key role in the reduction of adenosine uptake. Changes in PKC-alpha/beta activity were correlated with the attenuation of the ENT2 function in the short-term (2 h) but not in the long-term (7 d) period after the termination of morphine treatment. This study reveals a potential mechanism by which chronic exposure to morphine leads to impairment of both hippocampal LTP and spatial memory.

Morphine Protects Against Intracellular Amyloid Toxicity By Inducing Estradiol Release And Upregulation Of Hsp70

Prolonged Morphine Application Modulates Bax and Hsp70 Levels in Primary Rat Neurons

Chronic morphine application is protective against cell death in primary human neurons.

μ-Opioid receptor attenuates Aβ oligomers-induced neurotoxicity through mTOR signaling.

Morphine: a protective or destructive role in neurons?

The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson's Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy.

Modulation of Ca2+/calmodulin-dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of Alpha and Beta Isoforms.

Influences of morphine on the spontaneous and evoked excitatory postsynaptic currents in lateral amygdala of rats.

In vivo reduction of hippocampal Caveolin-1 by RNA interference alters morphine addiction and neuroplasticity changes in male mice

Chronic Morphine Treatment Induces Over-Expression of HSP70 in Mice Striatum Related with Abnormal Ubiquitin-Proteasome Degradation.

Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway

Endoplasmic Reticulum Stress in Spinal Cord Contributes to the Development of Morphine Tolerance

Morphine induces Beclin 1- and ATG5-dependent autophagy in human neuroblastoma SH-SY5Y cells and in the rat hippocampus.

Rescue of HSP70 in Spinal Neurons Alleviates Opioids-Induced Hyperalgesia Via the Suppression of Endoplasmic Reticulum Stress in Rodents.

The role of caveolin-1 in morphine-induced structural plasticity in primary cultured mouse cerebral cortical neurons.

Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors

Molecular Chaperone Heat Shock Protein 70 Inhibitors Suppress Conditioned Place Preference Induced by Morphine Exposure in Male Rats.

Oligomerization of MrgC11 and Μ-Opioid Receptors in Sensory Neurons Enhances Morphine Analgesia.

Interactive effects of morphine and dopamine receptor agonists on spatial recognition memory in mice.

Morphine modulates glutamate release in the hippocampal CA1 area in mice.

Effects of morphine and NeuroAid on the expression levels of GluN2A and GluN3A in the hippocampus and striatum of rats